These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2809253)

  • 21. Monoclonal antibodies to the large glycoproteins of respiratory syncytial virus: possible evidence for several functional antigenic sites.
    Tsutsumi H; Flanagan TD; Ogra PL
    J Gen Virol; 1987 Aug; 68 ( Pt 8)():2161-7. PubMed ID: 2440982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research Progress in the F Gene and Protein of the Respiratory Syncytial Virus].
    Zhang F; Xie Z
    Bing Du Xue Bao; 2015 Mar; 31(2):201-6. PubMed ID: 26164949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for the role of glycoprotein G of respiratory syncytial virus in binding of Neisseria meningitidis to HEp-2 cells.
    Raza MW; Blackwell CC; Ogilvie MM; Saadi AT; Stewart J; Elton RA; Weir DM
    FEMS Immunol Med Microbiol; 1994 Nov; 10(1):25-30. PubMed ID: 7874075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease.
    Lee YN; Hwang HS; Kim MC; Lee YT; Lee JS; Moore ML; Kang SM
    Antiviral Res; 2015 Mar; 115():1-8. PubMed ID: 25513755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RSV neutralization by palivizumab, but not by monoclonal antibodies targeting other epitopes, is augmented by Fc gamma receptors.
    van Mechelen L; Luytjes W; de Haan CA; Wicht O
    Antiviral Res; 2016 Aug; 132():1-5. PubMed ID: 27185625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Productive infection of isolated human alveolar macrophages by respiratory syncytial virus.
    Panuska JR; Cirino NM; Midulla F; Despot JE; McFadden ER; Huang YT
    J Clin Invest; 1990 Jul; 86(1):113-9. PubMed ID: 2365811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.
    Anderson LJ; Hierholzer JC; Tsou C; Hendry RM; Fernie BF; Stone Y; McIntosh K
    J Infect Dis; 1985 Apr; 151(4):626-33. PubMed ID: 2579169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
    Johnson TR; Graham BS
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanobodies® specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion.
    Schepens B; Ibañez LI; De Baets S; Hultberg A; Bogaert P; De Bleser P; Vervalle F; Verrips T; Melero J; Vandevelde W; Vanlandschoot P; Saelens X
    J Infect Dis; 2011 Dec; 204(11):1692-701. PubMed ID: 21998474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bispecific antibody targeting of human immunodeficiency virus type 1 (HIV-1) glycoprotein 41 to human macrophages through the Fc IgG receptor I mediates neutralizing effects in HIV-1 infection.
    Mabondzo A; Aussage P; Bartholeyns J; Le Naour R; Raoul H; Romet-Lemonne JL; Dormont D
    J Infect Dis; 1992 Jul; 166(1):93-9. PubMed ID: 1535093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells.
    Cortjens B; Yasuda E; Yu X; Wagner K; Claassen YB; Bakker AQ; van Woensel JBM; Beaumont T
    J Virol; 2017 May; 91(10):. PubMed ID: 28275185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.
    Schickli JH; Whitacre DC; Tang RS; Kaur J; Lawlor H; Peters CJ; Jones JE; Peterson DL; McCarthy MP; Van Nest G; Milich DR
    J Clin Invest; 2015 Apr; 125(4):1637-47. PubMed ID: 25751145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.
    O'Konek JJ; Makidon PE; Landers JJ; Cao Z; Malinczak CA; Pannu J; Sun J; Bitko V; Ciotti S; Hamouda T; Wojcinski ZW; Lukacs NW; Fattom A; Baker JR
    Hum Vaccin Immunother; 2015; 11(12):2904-12. PubMed ID: 26307915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies.
    Taylor G; Stott EJ; Furze J; Ford J; Sopp P
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2217-23. PubMed ID: 1383403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein.
    Chen Z; Zhang L; Tang A; Callahan C; Pristatsky P; Swoyer R; Cejas P; Nahas D; Galli J; Cosmi S; DiStefano D; Hoang VM; Bett A; Casimiro D; Vora KA
    PLoS One; 2016; 11(6):e0156798. PubMed ID: 27258388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model.
    Ponnuraj EM; Springer J; Hayward AR; Wilson H; Simoes EA
    J Infect Dis; 2003 Apr; 187(8):1257-63. PubMed ID: 12696005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of antibody-induced modulation of respiratory syncytial virus antigens in a human epithelial cell line.
    Sarmiento RE; Tirado RG; Valverde LE; Gómez-Garcia B
    Virol J; 2007 Jul; 4():68. PubMed ID: 17608950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivo.
    Jacobino SR; Nederend M; Reijneveld JF; Augustijn D; Jansen JHM; Meeldijk J; Reiding KR; Wuhrer M; Coenjaerts FEJ; Hack CE; Bont LJ; Leusen JHW
    MAbs; 2018 Apr; 10(3):453-462. PubMed ID: 29553863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats.
    Kamphuis T; Shafique M; Meijerhof T; Stegmann T; Wilschut J; de Haan A
    Vaccine; 2013 Apr; 31(17):2169-76. PubMed ID: 23499594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of an adeno-vector vaccine expressing the F protein of a respiratory syncytial virus manufactured from serum-free suspension culture.
    Shao HY; Hsu HS; Yu SL; Wu SR; Hu KC; Chang CK; Liu CC; Chow YH
    Antiviral Res; 2016 Jun; 130():27-35. PubMed ID: 27001351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.